A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection.

Mulley, William R; Hudson, Fiona J; Tait, Brian D; Skene, Alison M; Dowling, John P; Kerr, Peter G; Kanellis, John

Mulley, William R; Hudson, Fiona J; Tait, Brian D; Skene, Alison M; Dowling, John P; Kerr, Peter G; Kanellis, John.

Affiliation

Mulley WR; Department of Nephrology, Monash Medical Centre, Clayton, Australia. bill.mulley@southernhealth.org.au

Transplantation ; 87(2): 286-9, 2009 Jan 27.

Article in En | MEDLINE | ID: mdl-19155986

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antibody Formation/drug effects; Graft Rejection/drug therapy; Graft Survival/drug effects; Kidney Transplantation/immunology; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes/drug effects; B-Lymphocytes/immunology; Creatinine/blood; Female; Graft Rejection/immunology; Graft Survival/immunology; Humans; Immunoglobulins, Intravenous/administration & dosage; Male; Middle Aged; Pilot Projects; Plasma Exchange; Rituximab; Salvage Therapy; Time Factors; Treatment Outcome; Virus Diseases/immunology; Virus Diseases/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Graft Rejection / Graft Survival / Antibodies, Monoclonal / Antibody Formation Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google